Two Tuberculosis Regimens Containing Novel Agents Show Promise
(MedPage Today) -- Two four-drug regimens that combined new agents with commonly used drugs showed promise in tuberculosis (TB), and should be evaluated further, results from a phase II trial suggested. The time to positivity slope -- the rate...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
